NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

蛋白酶K的全球市場分析 - 各治療領域·不同形狀 (2025年):新型冠狀病毒感染疾病 (COVID-19)累積的影響

Proteinase K Market Research Report by Therapeutic Area (Autoimmune Diseases, Cardiology, Diabetes, Infectious Diseases, and Nephrology), by Form (Liquid and Powder) - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 972403
出版日期 內容資訊 英文 191 Pages
商品交期: 最快1-2個工作天內
價格
蛋白酶K的全球市場分析 - 各治療領域·不同形狀 (2025年):新型冠狀病毒感染疾病 (COVID-19)累積的影響 Proteinase K Market Research Report by Therapeutic Area (Autoimmune Diseases, Cardiology, Diabetes, Infectious Diseases, and Nephrology), by Form (Liquid and Powder) - Global Forecast to 2025 - Cumulative Impact of COVID-19
出版日期: 2021年02月04日內容資訊: 英文 191 Pages
簡介

全球蛋白酶K的市場規模在2019年估算為5159萬美元,擴大到2025年終7974萬美元,以7.52%的年複合成長率成長

本報告提供全球蛋白酶K的市場相關調查,彙整市場最新趨勢和促進·阻礙因素,整體市場規模趨勢預測,各治療領域·不同形狀及地區別·主要國家詳細趨勢,市場佔有率結構和最新的市場競爭趨勢,主要企業的簡介,新型冠狀病毒感染疾病 (COVID-19) 迄今累積的影響等資訊,為您概述為以下內容。

目錄

第1章 序論

第2章 調查手法

第3章 摘要整理

第4章 市場概要

第5章 市場動態

  • 簡介
  • 促進因素
  • 阻礙因素
  • 市場機會
  • 課題

第6章 市場考察

  • 波特的五力分析
    • 新加入企業的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供應商談判力
    • 產業內部的競爭狀態
  • COVID-19累積的影響
  • 客戶的客制化

第7章 全球蛋白酶K市場:各治療領域

  • 簡介
  • 自體免疫疾病
  • 心臟病
  • 糖尿病
  • 感染疾病
  • 腎臟病
  • 神經症
  • 腫瘤
  • 其他

第8章 全球蛋白酶K市場:不同形狀

  • 簡介
  • 液體
  • 粉末

第9章 南北美洲的蛋白酶K市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區的蛋白酶K市場

  • 簡介
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章 歐洲·中東·非洲的蛋白酶K市場

  • 簡介
  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國 (UAE)
  • 英國

第12章 競爭情形

  • FPNV定位·矩陣
    • 市場區隔
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 競爭模式
    • 企業合併·收購 (M&A)
    • 協定,事業合作·聯盟
    • 新產品的銷售與改良
    • 投資·資金籌措
    • 獲獎·認證·擴張

第13章 企業的實用性·簡介

  • Advanced Enzymes Technologies Ltd.
  • Affymetrix
  • Amano Enzyme Inc.
  • American Laboratories
  • Amicogen
  • BBI Solutions
  • Biocatalysts Ltd.
  • BIORON GmbH
  • Codexis, Inc.
  • Dyadic International
  • F. Hoffmann-La Roche Ltd.
  • Gproan Biotechnologies
  • Merck KGaA
  • Norgen Biotek Corp.
  • Novus Biologicals
  • Promega Corporation
  • Qiagen N.V.
  • Sisco Research Laboratories Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
  • Worthington Biochemical Corporation

第14章 附錄

目錄
Product Code: MRR-6263B29

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Proteinase K Market is expected to grow from USD 55.35 Million in 2020 to USD 79.74 Million by the end of 2025.

2. The Global Proteinase K Market is expected to grow from EUR 48.54 Million in 2020 to EUR 69.92 Million by the end of 2025.

3. The Global Proteinase K Market is expected to grow from GBP 43.15 Million in 2020 to GBP 62.16 Million by the end of 2025.

4. The Global Proteinase K Market is expected to grow from JPY 5,908.24 Million in 2020 to JPY 8,511.26 Million by the end of 2025.

5. The Global Proteinase K Market is expected to grow from AUD 80.38 Million in 2020 to AUD 115.80 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Proteinase K to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Therapeutic Area, the Proteinase K Market studied across Autoimmune Diseases, Cardiology, Diabetes, Infectious Diseases, Nephrology, Neurology, Oncology, and Others.

Based on Form, the Proteinase K Market studied across Liquid and Powder.

Based on Geography, the Proteinase K Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Proteinase K Market including Advanced Enzymes Technologies Ltd., Affymetrix, Amano Enzyme Inc., American Laboratories, Amicogen, BBI Solutions, Biocatalysts Ltd., BIORON GmbH, Codexis, Inc., Dyadic International, F. Hoffmann-La Roche Ltd., Gproan Biotechnologies, Merck KGaA, Norgen Biotek Corp., Novus Biologicals, Promega Corporation, Qiagen N.V., Sisco Research Laboratories Pvt. Ltd., Thermo Fisher Scientific Inc., and Worthington Biochemical Corporation.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Proteinase K Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Proteinase K Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Proteinase K Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Proteinase K Market?

4. What is the competitive strategic window for opportunities in the Global Proteinase K Market?

5. What are the technology trends and regulatory frameworks in the Global Proteinase K Market?

6. What are the modes and strategic moves considered suitable for entering the Global Proteinase K Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Form Outlook
  • 3.4. Therapeutic Area Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for nucleic acid purification
      • 5.1.1.2. Improved cloning efficiency and tissue digestion
      • 5.1.1.3. Growing importance of various chemicals in manufacturing food and beverage
    • 5.1.2. Restraints
      • 5.1.2.1. Good availability of other proteases
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing R&D in the field like 3D printing and tissue reengineering
      • 5.1.3.2. Government initiatives taken in pharmaceutical industry
    • 5.1.4. Challenges
      • 5.1.4.1. Introduction of new sophisticated technologies for DNA purification
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Proteinase K Market, By Therapeutic Area

  • 6.1. Introduction
  • 6.2. Autoimmune Diseases
  • 6.3. Cardiology
  • 6.4. Diabetes
  • 6.5. Infectious Diseases
  • 6.6. Nephrology
  • 6.7. Neurology
  • 6.8. Oncology
  • 6.9. Others

7. Global Proteinase K Market, By Form

  • 7.1. Introduction
  • 7.2. Liquid
  • 7.3. Powder

8. Americas Proteinase K Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Proteinase K Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. South Korea
  • 9.10. Thailand

10. Europe, Middle East & Africa Proteinase K Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis
  • 11.4. Competitor SWOT Analysis
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Advanced Enzymes Technologies Ltd.
  • 12.2. Affymetrix
  • 12.3. Amano Enzyme Inc.
  • 12.4. American Laboratories
  • 12.5. Amicogen
  • 12.6. BBI Solutions
  • 12.7. Biocatalysts Ltd.
  • 12.8. BIORON GmbH
  • 12.9. Codexis, Inc.
  • 12.10. Dyadic International
  • 12.11. F. Hoffmann-La Roche Ltd.
  • 12.12. Gproan Biotechnologies
  • 12.13. Merck KGaA
  • 12.14. Norgen Biotek Corp.
  • 12.15. Novus Biologicals
  • 12.16. Promega Corporation
  • 12.17. Qiagen N.V.
  • 12.18. Sisco Research Laboratories Pvt. Ltd.
  • 12.19. Thermo Fisher Scientific Inc.
  • 12.20. Worthington Biochemical Corporation

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

List of Figures

  • FIGURE 1. GLOBAL PROTEINASE K MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL PROTEINASE K MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL PROTEINASE K MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL PROTEINASE K MARKET SIZE, BY FORM, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL PROTEINASE K MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 8. GLOBAL PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 9. GLOBAL PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 11. GLOBAL PROTEINASE K MARKET: MARKET DYNAMICS
  • FIGURE 12. GLOBAL PROTEINASE K MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 13. GLOBAL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2025 (%)
  • FIGURE 14. GLOBAL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2025 (USD MILLION)
  • FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2025
  • FIGURE 16. GLOBAL PROTEINASE K MARKET SIZE, BY AUTOIMMUNE DISEASES, 2020 VS 2025 (USD MILLION)
  • FIGURE 17. GLOBAL PROTEINASE K MARKET SIZE, BY CARDIOLOGY, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL PROTEINASE K MARKET SIZE, BY DIABETES, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL PROTEINASE K MARKET SIZE, BY INFECTIOUS DISEASES, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL PROTEINASE K MARKET SIZE, BY NEPHROLOGY, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL PROTEINASE K MARKET SIZE, BY NEUROLOGY, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL PROTEINASE K MARKET SIZE, BY ONCOLOGY, 2020 VS 2025 (USD MILLION)
  • FIGURE 23. GLOBAL PROTEINASE K MARKET SIZE, BY OTHERS, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. GLOBAL PROTEINASE K MARKET SIZE, BY FORM, 2020 VS 2025 (%)
  • FIGURE 25. GLOBAL PROTEINASE K MARKET SIZE, BY FORM, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROTEINASE K MARKET SIZE, BY FORM, 2025
  • FIGURE 27. GLOBAL PROTEINASE K MARKET SIZE, BY LIQUID, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. GLOBAL PROTEINASE K MARKET SIZE, BY POWDER, 2020 VS 2025 (USD MILLION)
  • FIGURE 29. AMERICAS PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 30. AMERICAS PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 32. ARGENTINA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 33. BRAZIL PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 34. CANADA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 35. MEXICO PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 36. UNITED STATES PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 37. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 38. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 40. AUSTRALIA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 41. CHINA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 42. INDIA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 43. INDONESIA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 44. JAPAN PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 45. MALAYSIA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. PHILIPPINES PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. SOUTH KOREA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 48. THAILAND PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 50. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 52. FRANCE PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. GERMANY PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. ITALY PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. NETHERLANDS PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. QATAR PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. RUSSIA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 58. SAUDI ARABIA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. SOUTH AFRICA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. SPAIN PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. UNITED ARAB EMIRATES PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 62. UNITED KINGDOM PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 63. GLOBAL PROTEINASE K MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 64. GLOBAL PROTEINASE K MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 65. GLOBAL PROTEINASE K MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PROTEINASE K MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL PROTEINASE K MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL PROTEINASE K MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL PROTEINASE K MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL PROTEINASE K MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL PROTEINASE K MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL PROTEINASE K MARKET SIZE, BY NEPHROLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL PROTEINASE K MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL PROTEINASE K MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL PROTEINASE K MARKET SIZE, BY OTHERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL PROTEINASE K MARKET SIZE, BY LIQUID, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL PROTEINASE K MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. ARGENTINA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. ARGENTINA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. BRAZIL PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. BRAZIL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. CANADA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CANADA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. MEXICO PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. MEXICO PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. UNITED STATES PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. UNITED STATES PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. AUSTRALIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. AUSTRALIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. CHINA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CHINA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. INDIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. INDIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. INDONESIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. INDONESIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. JAPAN PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. JAPAN PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. MALAYSIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. MALAYSIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. PHILIPPINES PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. PHILIPPINES PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. SOUTH KOREA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. SOUTH KOREA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. THAILAND PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. THAILAND PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. FRANCE PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. FRANCE PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. GERMANY PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. GERMANY PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ITALY PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ITALY PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. NETHERLANDS PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. NETHERLANDS PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. QATAR PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. QATAR PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. RUSSIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. RUSSIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. SAUDI ARABIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. SAUDI ARABIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. SOUTH AFRICA PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. SOUTH AFRICA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. SPAIN PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. SPAIN PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. UNITED ARAB EMIRATES PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. UNITED ARAB EMIRATES PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. UNITED KINGDOM PROTEINASE K MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. UNITED KINGDOM PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. GLOBAL PROTEINASE K MARKET: SCORES
  • TABLE 76. GLOBAL PROTEINASE K MARKET: BUSINESS STRATEGY
  • TABLE 77. GLOBAL PROTEINASE K MARKET: PRODUCT SATISFACTION
  • TABLE 78. GLOBAL PROTEINASE K MARKET: RANKING
  • TABLE 79. GLOBAL PROTEINASE K MARKET: MERGER & ACQUISITION
  • TABLE 80. GLOBAL PROTEINASE K MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 81. GLOBAL PROTEINASE K MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 82. GLOBAL PROTEINASE K MARKET: INVESTMENT & FUNDING
  • TABLE 83. GLOBAL PROTEINASE K MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 84. GLOBAL PROTEINASE K MARKET: LICENSE & PRICING